The local lymph node assay: past, present and future
- PMID: 12581276
- DOI: 10.1034/j.1600-0536.2002.470601.x
The local lymph node assay: past, present and future
Abstract
The local lymph node assay (LLNA) was developed originally as a method for the identification of chemicals that have the potential to cause skin sensitization and allergic contact dermatitis. The assay is based on an understanding that the acquisition of contact sensitization is associated with, and dependent upon, the stimulation by chemical allergens of lymphocyte proliferative responses in skin-draining lymph nodes. Those chemicals that provoke a defined level of lymph node cell (LNC) proliferation (a 3-fold or greater increase compared with concurrent vehicle controls) are classified as skin sensitizers. Following its original inception and development, the LLNA was the subject of both national and international interlaboratory collaborative trials, and of very detailed comparisons with other test methods and with human skin sensitization data. The assay has now been validated fully as a stand-alone test for the purposes of hazard identification. In recent years, there has been a growing interest also in the use of the LLNA to assess the potency of contact allergens and in risk assessment. There is reason to believe that the extent of skin sensitization achieved is associated with the vigour of LNC proliferation induced in draining nodes. Given this relationship, the relative potency of skin sensitizing chemicals is measured in the LLNA by derivation of an EC3 value, this being the concentration of chemical required to provoke a 3-fold increase in the proliferation of LNC compared with controls. Experience to date indicates that relative potency as determined using this approach correlates closely with what is known of the activity of skin sensitizing chemicals in humans. In this article, we review the development, evaluation and validation of the LLNA for the purposes of hazard identification, and the more recent application of the method for evaluation of potency in the context of risk assessment. In addition, we consider what new applications and modifications are currently being investigated.
Similar articles
-
The local lymph node assay and the assessment of relative potency: status of validation.Contact Dermatitis. 2007 Aug;57(2):70-5. doi: 10.1111/j.1600-0536.2007.01141.x. Contact Dermatitis. 2007. PMID: 17627643 Review.
-
The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.Cutan Ocul Toxicol. 2008;27(2):67-75. doi: 10.1080/15569520801904655. Cutan Ocul Toxicol. 2008. PMID: 18568891
-
Contact allergenic potency: correlation of human and local lymph node assay data.Am J Contact Dermat. 2001 Sep;12(3):156-61. doi: 10.1053/ajcd.2001.23926. Am J Contact Dermat. 2001. PMID: 11526521
-
Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.Methods. 2007 Jan;41(1):54-60. doi: 10.1016/j.ymeth.2006.07.006. Methods. 2007. PMID: 16938465 Review.
-
Skin sensitization testing in potency and risk assessment.Toxicol Sci. 2001 Feb;59(2):198-208. doi: 10.1093/toxsci/59.2.198. Toxicol Sci. 2001. PMID: 11158712 Review.
Cited by
-
A convenient spectrophotometric test for screening skin-sensitizing chemicals using reactivity with glutathione in chemico.Toxicol Res. 2023 Dec 13;40(2):203-213. doi: 10.1007/s43188-023-00218-9. eCollection 2024 Apr. Toxicol Res. 2023. PMID: 38525138 Free PMC article.
-
Contact dermatitis.Nat Rev Dis Primers. 2021 May 27;7(1):38. doi: 10.1038/s41572-021-00271-4. Nat Rev Dis Primers. 2021. PMID: 34045488 Review.
-
In vitro methods for hazard assessment of industrial chemicals - opportunities and challenges.Front Pharmacol. 2015 May 5;6:94. doi: 10.3389/fphar.2015.00094. eCollection 2015. Front Pharmacol. 2015. PMID: 25999858 Free PMC article. Review.
-
In Vitro Prediction of Skin-Sensitizing Potency Using the GARDskin Dose-Response Assay: A Simple Regression Approach.Toxics. 2024 Aug 24;12(9):626. doi: 10.3390/toxics12090626. Toxics. 2024. PMID: 39330554 Free PMC article.
-
Immunotoxicology: role in the safety assessment of drugs.Drug Saf. 2005;28(2):127-36. doi: 10.2165/00002018-200528020-00004. Drug Saf. 2005. PMID: 15691223 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous